Eli Lilly (LLY) Stock Surges 4% Following Breakthrough Sleep Apnea Trial Results
Key Takeaways Eli Lilly shares climbed over 4% during early Monday session following weekend disclosure of promising clinical trial results. The company’s investigational obesity medication r








